Literature DB >> 17162241

The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life.

Lesley A Graff1, John R Walker, Lisa Lix, Ian Clara, Patricia Rawsthorne, Linda Rogala, Norine Miller, Laura Jakul, Cory McPhail, Jason Ediger, Charles N Bernstein.   

Abstract

BACKGROUND & AIMS: We aimed to assess the relationship of disease type and disease activity with psychological functioning and quality of life (QOL) in a population-based cohort of patients with recently diagnosed inflammatory bowel disease (IBD).
METHODS: A total of 388 individuals diagnosed within 7 years were recruited from a population-based registry of IBD patients for the Manitoba IBD Cohort Study. Participants completed a clinical interview and standardized self-report measures of positive and negative psychological functioning, and QOL. Disease activity was determined by symptom self-report over the prior 6 months; Harvey-Bradshaw or Powell-Tuck disease activity indices also were used. Disease type was determined through chart verification.
RESULTS: Seventy-four percent of Crohn's disease and 66% of ulcerative colitis participants had active disease during the previous 6 months. Multivariate regression showed that those with active disease had higher levels of distress, health anxiety, and perceived stress, lower social support, well-being and mastery, and poorer disease-specific QOL, relative to those with inactive disease. Disease type was not contributory to psychological functioning or QOL. Pain anxiety (fear of pain) and pain-specific catastrophizing were not associated with disease activity, after controlling for other psychological variables. Participants with either active or inactive disease had suboptimal general QOL.
CONCLUSIONS: Ulcerative colitis and Crohn's disease participants were not differentiated in their psychological profiles. Given the strong association between disease-specific QOL, psychological functioning, and disease activity, it is important to be aware of related difficulties in patients with active IBD. There is a continued impact on QOL by the disease, even when it is inactive.

Entities:  

Mesh:

Year:  2006        PMID: 17162241     DOI: 10.1016/j.cgh.2006.09.027

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  79 in total

Review 1.  Pain and inflammatory bowel disease.

Authors:  Klaus Bielefeldt; Brian Davis; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

2.  A comparison of self-perceived health status in inflammatory bowel disease and irritable bowel syndrome patients from a Canadian national population survey.

Authors:  Linda Y L Tang; Alice Nabalamba; Leslie A Graff; Charles N Bernstein
Journal:  Can J Gastroenterol       Date:  2008-05       Impact factor: 3.522

3.  Measures of relative importance for health-related quality of life.

Authors:  Tolulope T Sajobi; Lisa M Lix; Ian Clara; John Walker; Lesley A Graff; Patricia Rawsthorne; Norine Miller; Linda Rogala; Rachel Carr; Charles N Bernstein
Journal:  Qual Life Res       Date:  2011-04-24       Impact factor: 4.147

4.  Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial.

Authors:  Remo Panaccione; Edward V Loftus; David Binion; Kevin McHugh; Shamsul Alam; Naijun Chen; Benoît Guerette; Parvez Mulani; Jingdong Chao
Journal:  Can J Gastroenterol       Date:  2011-08       Impact factor: 3.522

5.  Altered STAT4 Isoform Expression in Patients with Inflammatory Bowel Disease.

Authors:  Rukhsana Jabeen; Lucy Miller; Weiguo Yao; Sandeep Gupta; Steven Steiner; Mark H Kaplan
Journal:  Inflamm Bowel Dis       Date:  2015-10       Impact factor: 5.325

Review 6.  Inflammatory bowel disease: a Canadian burden of illness review.

Authors:  Angela Rocchi; Eric I Benchimol; Charles N Bernstein; Alain Bitton; Brian Feagan; Remo Panaccione; Kevin W Glasgow; Aida Fernandes; Subrata Ghosh
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

7.  Perianal disease is associated with psychiatric co-morbidity in Crohn's disease in remission.

Authors:  Giovanni Maconi; Daniele Gridavilla; Caterina Viganò; Roberta Sciurti; Anil K Asthana; Federica Furfaro; Federica Re; Sandro Ardizzone; Gabriella Ba
Journal:  Int J Colorectal Dis       Date:  2014-07-02       Impact factor: 2.571

8.  Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease.

Authors:  Sara Horst; Andrew Chao; Michael Rosen; Anne Nohl; Caroline Duley; Julianne H Wagnon; Dawn B Beaulieu; Warren Taylor; Lawrence Gaines; David A Schwartz
Journal:  Dig Dis Sci       Date:  2014-10-02       Impact factor: 3.199

9.  Mechanisms of Quality of Life and Social Support in Inflammatory Bowel Disease.

Authors:  Laura Katz; Dean A Tripp; Mark Ropeleski; William Depew; J Curtis Nickel; Stephen Vanner; Michael J Beyak
Journal:  J Clin Psychol Med Settings       Date:  2016-03

10.  The effects of body image impairment on the quality of life of non-operated Portuguese female IBD patients.

Authors:  Inês A Trindade; Cláudia Ferreira; José Pinto-Gouveia
Journal:  Qual Life Res       Date:  2016-07-25       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.